Operating income increased 55.5%
Operating income changed +55.5% from the comparable as-filed period.
-$2.0M→-$890,6373 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →NTRB financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents decreased 51.1%
Cash & equivalents changed -51.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$7.0M→$3.4M4 prior comparisons
Trade receivables decreased 85.3%
Trade receivables changed -85.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$160,804→$23,5924 prior comparisons
Operating margin moved 11826 bp higher
Operating margin changed +11826 basis points from the comparable as-filed period.
-321.83%→-203.57%3 prior comparisons
Net income increased 56.0%
Net income changed +56.0% from the comparable as-filed period.
-$2.0M→-$880,5613 prior comparisons
Selling, general & administrative decreased 53.0%
Selling, general & administrative changed -53.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$1.6M→$750,3173 prior comparisons
Current assets decreased 49.2%
Current assets changed -49.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$7.5M→$3.8M4 prior comparisons
Working capital decreased 51.0%
Working capital changed -51.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$5.9M→$2.9M4 prior comparisons
Revenue decreased 29.7%
Revenue changed -29.7% from the comparable as-filed period.
$622,452→$437,5143 prior comparisons
Research & development decreased 42.7%
Research & development changed -42.7% from the comparable as-filed period.
$562,554→$322,1943 prior comparisons
Operating cash-flow margin moved 7728 bp higher
Operating cash-flow margin changed +7728 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-210.99%→-133.71%3 prior comparisons
Working capital / assets moved 1218 bp lower
Working capital / assets changed -1218 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
58.45%→46.28%4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.